Company profile

Ticker
AZN
Exchange
CEO
Pascal Soriot
Employees
Location
Fiscal year end
Former names
Zeneca Group PLC
SEC CIK

AZN stock data

(
)

Calendar

5 Mar 19
15 Sep 19
31 Dec 19

News

Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
6th grade Good
New words: Absent, absolute, Academy, Actuarial, Additionally, ADP, Aerosphere, affordability, aforementioned, anaesthetic, analogue, approach, Arabian, Aralez, Aspen, aspirin, assistance, asthma, AZN, BCise, began, Bevespi, biennial, biologic, Biovitrum, bolstered, Brazil, BRCAm, broad, broader, bronchodilator, buying, Bydureon, Byetta, Calquence, carcinoma, Circassia, classification, closure, commentary, competitor, composite, concentrated, conjunction, contrasting, cooperated, COPD, coverage, creditor, CRT, cut, CV, CVMD, CVRM, DAC, Daiichi, demonstrated, diminished, discontinued, Document, dual, Dualkir, duration, EBITDA, education, EGFR, EGFRm, eligibility, eligible, eliminating, emanating, encouraging, endocrine, enzyme, eosinophilic, epidermal, estimate, exceed, exceeding, expiry, exposure, extension, FALCON, false, Fasenra, Faslodex, faster, fell, felt, finalised, Fluenz, Food, France, freeze, grow, growing, hemisphere, highlighting, illustrated, inappropriately, inflammatory, influenza, inhaled, insolvency, Instance, insulin, intensity, IR, Japanese, Kemp, kinase, label, LAMA, legacy, lengthening, Linkbase, linked, Luye, MACE, matured, maximise, MCL, Medicaid, met, metoprolol, mitigated, Movantik, moved, National, nature, nebulisation, necessity, negative, negotiation, NMPA, notable, NRDL, objection, Ono, opportunity, originally, outweighed, overwhelming, PARP, passage, patient, payer, penetration, pharmacy, pilot, placebo, POLO, poly, polymerase, population, predominantly, prevailing, prioritisation, produce, promising, promote, proof, proprietary, published, qui, realized, recede, reclassified, recognition, Recordati, reimbursement, relief, renewed, resource, restriction, retranslation, ribose, rolled, round, Russia, Sankyo, Saudi, Schema, seal, Seloken, shift, Signatory, situation, slowly, Sobi, SoC, stabilised, statin, statistically, statute, strength, study, successful, succinate, symbol, Taxonomy, terminated, track, trend, Trustee, Tudorza, tyrosine, underlined, underlining, underpinned, undertaken, underway, Unfavourable, unrecognised, unsecured, uptake, usage, utilisation, utilised, Valuation, Venezuela, voluntary, weakened, welfare, Western, withdrew, XBRL, Zavicefta, Zomig
Removed: ADS, AG, arm, Astra, California, call, cardiac, closing, created, death, defending, Delaware, Director, distributed, Dow, failure, family, heart, infringement, Jersey, KB, KBI, litigation, LSE, manufacture, Master, Merck, middle, pending, put, ratio, relationship, research, retroactively, Room, settlement, SSE, Stockholm, Street, ultimate, USA, view

Proxies

No filings